Adial Pharmaceuticals

(NASDAQ) ADIL

Current Price$2.62

Market Cap$5.81M

Since IPO (2018)-100%

5 Year-100%

1 Year-56%

1 Month+30%

Adial Pharmaceuticals Financials at a Glance

Market Cap

$5.81M

Revenue (TTM)

$0.00

Net Income (TTM)

-$7.77M

EPS (TTM)

-$9.90

P/E Ratio

-0.27

Dividend

$0.00

Beta (Volatility)

0.77 (Low)

Dividend

$0.00

Beta (Volatility)

0.77 (Low)

Price

$2.62

Volume

638

Open

$2.61

Price

$2.62

Volume

638

Open

$2.61

Previous Close

$2.71

Daily Range

$2.53 - $2.89

52-Week Range

$1.31 - $18.90

Estimated Earnings Date

Aug 19, 2026

Dividend

$0.00

Beta (Volatility)

0.77 (Low)

Price

$2.62

Volume

638

Open

$2.61

Previous Close

$2.71

Daily Range

$2.53 - $2.89

52-Week Range

$1.31 - $18.90

Estimated Earnings Date

Aug 19, 2026

ADIL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Adial Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Cary J. Claiborne, MBA

Website

www.adial.com

Headquarters

Charlottesville, VA 22901, US

ADIL Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-266%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-3.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.81M

Shares Outstanding

2.14M

Volume

638

Avg. Volume

472.40K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$7.80M

EBITDA

-$7.98M

Operating Cash Flow

-$6.49M

Capital Expenditure

$3.00

Free Cash Flow

-$6.49M

Cash & ST Invst.

$5.88M

Total Debt

$0.00

Adial Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$141.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$5.81M

N/A

Market Cap/Employee

$1.16M

N/A

Employees

N/A

Net Income

-$2.02M

+9.3%

EBITDA

-$2.02M

+9.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$4.58M

+93.8%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.49%

N/A

Return on Invested Capital

-2.03%

N/A

Free Cash Flow

-$1.61M

-1.7%

Operating Cash Flow

-$1.61M

-1.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BCDABioCardia, Inc.

BCDABioCardia, Inc.$0.97-0.06%

APREAprea Therapeutics, Inc.

APREAprea Therapeutics, Inc.$0.79+10.99%

CELZCreative Medical Technology Holdings, Inc.

CELZCreative Medical Technology Holdings, Inc.$1.93-13.45%

CDIOCardio Diagnostics Holdings, Inc.

CDIOCardio Diagnostics Holdings, Inc.$1.97-0.51%

HCWBHCW Biologics Inc.

HCWBHCW Biologics Inc.$1.16+6.42%

ACXPAcurx Pharmaceuticals, Inc.

ACXPAcurx Pharmaceuticals, Inc.$1.51-1.95%

BCLIBrainstorm Cell Therapeutics Inc.

BCLIBrainstorm Cell Therapeutics Inc.$0.90+4.11%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.93+0.00%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$154.60-0.16%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$82.58-0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.47+0.02%

ONDSOndas

ONDSOndas$8.89-0.04%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.66+0.06%

TET1 Energy Inc.

TET1 Energy Inc.$10.40+0.11%

Questions About ADIL

What is the current price of Adial Pharmaceuticals?

Adial Pharmaceuticals is trading at $2.71 per share.

What is the 52-week range for Adial Pharmaceuticals?

Over the past 52 weeks, Adial Pharmaceuticals has traded between $1.31 and $18.90.

How much debt does Adial Pharmaceuticals have?

As of the most recent reporting period, Adial Pharmaceuticals reported total debt of $0.00.

How much cash does Adial Pharmaceuticals have on hand?

Adial Pharmaceuticals reported $4.58M in cash and cash equivalents in its most recent financial results.

What is Adial Pharmaceuticals’s dividend yield?

Adial Pharmaceuticals does not currently have a dividend yield.

Adial Pharmaceuticals

Adial Pharmaceuticals Financials at a Glance

ADIL News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Adial Pharmaceuticals

ADIL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Adial Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ADIL

What is the current price of Adial Pharmaceuticals?

What is the 52-week range for Adial Pharmaceuticals?

How much debt does Adial Pharmaceuticals have?

How much cash does Adial Pharmaceuticals have on hand?

What is Adial Pharmaceuticals’s dividend yield?

Premium Investing Services